153 related articles for article (PubMed ID: 35230981)
21. Infliximab-induced autoimmune hepatitis.
Jenkins A; Austin A; Hughes K; Sadowski B; Torres D
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34031069
[TBL] [Abstract][Full Text] [Related]
22. Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial.
Wang JB; Huang A; Wang Y; Ji D; Liang QS; Zhao J; Zhou G; Liu S; Niu M; Sun Y; Tian H; Teng GJ; Chang BX; Bi JF; Peng XX; Xin S; Xie H; Ma X; Mao YM; Liangpunsakul S; Saxena R; Aithal GP; Xiao XH; Zhao J; Zou Z
Aliment Pharmacol Ther; 2022 May; 55(10):1297-1310. PubMed ID: 35362188
[TBL] [Abstract][Full Text] [Related]
23. New Onset Autoimmune Hepatitis during Anti-Tumor Necrosis Factor-Alpha Treatment in Children.
Ricciuto A; Kamath BM; Walters TD; Frost K; Carman N; Church PC; Ling SC; Griffiths AM
J Pediatr; 2018 Mar; 194():128-135.e1. PubMed ID: 29274889
[TBL] [Abstract][Full Text] [Related]
24. Ornidazole-induced autoimmune hepatitis.
Ersöz G; Vardar R; Akarca US; Tekın F; Yilmaz F; Günşar F; Karasu Z
Turk J Gastroenterol; 2011 Oct; 22(5):494-9. PubMed ID: 22234756
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.
Foureau DM; Walling TL; Maddukuri V; Anderson W; Culbreath K; Kleiner DE; Ahrens WA; Jacobs C; Watkins PB; Fontana RJ; Chalasani N; Talwalkar J; Lee WM; Stolz A; Serrano J; Bonkovsky HL
Clin Exp Immunol; 2015 Apr; 180(1):40-51. PubMed ID: 25418487
[TBL] [Abstract][Full Text] [Related]
26. Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients.
Nociti V; Biolato M; De Fino C; Bianco A; Losavio FA; Lucchini M; Marrone G; Grieco A; Mirabella M
Brain Behav; 2018 Jun; 8(6):e00968. PubMed ID: 29729087
[TBL] [Abstract][Full Text] [Related]
27. Liver Injury Associated with Metamizole Exposure: Features of an Underestimated Adverse Event.
Weber S; Benesic A; Neumann J; Gerbes AL
Drug Saf; 2021 Jun; 44(6):669-680. PubMed ID: 33638811
[TBL] [Abstract][Full Text] [Related]
28. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
[TBL] [Abstract][Full Text] [Related]
29. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.
Sebode M; Schulz L; Lohse AW
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895915
[TBL] [Abstract][Full Text] [Related]
30. Recent Advances in the Histopathology of Drug-Induced Liver Injury.
Kleiner DE
Surg Pathol Clin; 2018 Jun; 11(2):297-311. PubMed ID: 29751876
[TBL] [Abstract][Full Text] [Related]
31. Acute hepatitis in a paediatric patient: immune-mediated drug-induced liver injury or albendazole-induced autoimmune hepatitis?
Dragutinović N; Barać A; Stevanović G; Đorđić I; Paglietti B; Micić J; Aleksić E; Stojnić J; Martinov Nestorov J
J Infect Dev Ctries; 2022 Oct; 16(10):1660-1663. PubMed ID: 36332223
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study.
Licata A; Maida M; Cabibi D; Butera G; Macaluso FS; Alessi N; Caruso C; Craxì A; Almasio PL
Dig Liver Dis; 2014 Dec; 46(12):1116-20. PubMed ID: 25224696
[TBL] [Abstract][Full Text] [Related]
33. Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report.
Takahashi A; Kanno Y; Takahashi Y; Sakamoto N; Monoe K; Saito H; Abe K; Yokokawa J; Irisawa A; Ohira H
World J Gastroenterol; 2008 Sep; 14(35):5474-7. PubMed ID: 18803363
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
[No Abstract] [Full Text] [Related]
35. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
Xu HM; Chen Y; Xu J; Zhou Q
World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
[TBL] [Abstract][Full Text] [Related]
36. Drug-induced liver injury with autoimmune features.
deLemos AS; Foureau DM; Jacobs C; Ahrens W; Russo MW; Bonkovsky HL
Semin Liver Dis; 2014 May; 34(2):194-204. PubMed ID: 24879983
[TBL] [Abstract][Full Text] [Related]
37. Clinical and Pathological Features of Immune Checkpoint Inhibitor-induced Liver Injury in Comparison with Drug-induced Liver Injury and Autoimmune Hepatitis.
Sunago K; Abe M; Yoshida O; Watanabe T; Nakamura Y; Imai Y; Koizumi Y; Hirooka M; Tokumoto Y; Hiasa Y
J Gastrointestin Liver Dis; 2023 Dec; 32(4):488-496. PubMed ID: 38147620
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune hepatitis in human immunodeficiency virus-infected patients: A case series and review of the literature.
Chaiteerakij R; Sanpawat A; Avihingsanon A; Treeprasertsuk S
World J Gastroenterol; 2019 Sep; 25(35):5388-5402. PubMed ID: 31558881
[TBL] [Abstract][Full Text] [Related]
39. Celecoxib-induced Liver Injury: Analysis of Published Case Reports and Cases Reported to the Food and Drug Administration.
Mukthinuthalapati PK; Fontana RJ; Vuppalanchi R; Chalasani N; Ghabril M
J Clin Gastroenterol; 2018 Feb; 52(2):114-122. PubMed ID: 28795997
[TBL] [Abstract][Full Text] [Related]
40. Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.
Ghabril M; Bonkovsky HL; Kum C; Davern T; Hayashi PH; Kleiner DE; Serrano J; Rochon J; Fontana RJ; Bonacini M;
Clin Gastroenterol Hepatol; 2013 May; 11(5):558-564.e3. PubMed ID: 23333219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
